CPRX Financials

Catalyst Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$31.49

Market Cap

$3.84B

P/E Ratio

13.3

EPS

$1.75

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$491.73M

Gross Profit

Operating Income

Net Income

$163.89M

EPS (Diluted)

$1.31

Balance Sheet Highlights

Total Assets

$851.41M

Total Liabilities

$123.78M

Shareholders Equity

Cash & Equivalents

$517.55M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$239.81M

CapEx

Free Cash Flow

Profitability Metrics

Operating Margin

44.7%

Net Margin

37.6%

ROE

27.5%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is CPRX revenue?

CPRX's most recent quarterly revenue was $491.73M. Annual revenue can be calculated by summing the four most recent quarters.

Is CPRX profitable?

CPRX reported a profit of $163.89M in the most recent quarter. The net profit margin is 37.6%.

What is CPRX market cap?

CPRX has a market capitalization of $3.84B, making it a mid-cap stock.

Does CPRX have debt?

View CPRX's balance sheet for debt information.

What is CPRX cash flow?

Cash flow data is available in the full financial statements.